Knowledge and perceptions of physicians about Evidence Based Management of hypertension in acute ischemic stroke patients

Similar documents
Hypertension Update 2014:

Prevalence of Hyperlipidemia in Adult Stroke Patient at Liaquat University Hospital Jamshoro, Sindh

Clinical Investigations

Healthcare Implications of Achieving JNC 7 Blood Pressure Goals in Clinical Practice

Blood Pressure Assessment Practices of Dental Hygienists

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

2. Measurement Specifications 3. Patient Messaging 4. Provider Messaging Other Recent Guidelines

Module. Module. Clinical Trials

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

JNC-8. (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure- 8) An Update on Hypertension Guidelines

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

Managing Hypertension in the Perioperative Arena

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

Continuing Medical Education Post-Test

DEPARTMENT OF GENERAL MEDICINE WELCOMES

The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University

2016 Physician Quality Reporting System (PQRS) GPRO Web Interface Measures List 12/18/2015

Objectives. Describe results and implications of recent landmark hypertension trials

NeuroPI Case Study: Anticoagulant Therapy

Use of Antihypertensive Medications in Patients with type -2 Diabetes in Ajman, UAE

Approximately 73.6 million adults in the United States have

Supplementary Online Content

Impact of Education and Physical Activity on awareness and control of Hypertension

Hypertension Update Background

In the Literature 1001 BP of 1.1 mm Hg). The trial was stopped early based on prespecified stopping rules because of a significant difference in cardi

Hypertension Update. Aaron J. Friedberg, MD

Awareness of Hypertension, Risk Factors and Complications among Attendants of a Primary Health Care Center In Jeddah, Saudi Arabia

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic

2014 Evidence-Based HTN Guideline: Preliminary Data from AMGA s Anceta Collaborative

Stable Angina Treatment Strategies and Current Practices in Lahore, Pakistan: A Cross-Sectional Analysis

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

Cardiovascular disease: Beat the Heart Disease and feel a Healthy Beat Therapeutic capacity presentation series V1.0.

Eubios Journal of Asian and International Bioethics

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

A Needs Assessment of Hypertension in Georgia

HIGH BLOOD PRESSURE. How can we do better?

Osama Sanad (MD) Prof. of Cardiology Benha University 2016

GOVERNING BODY REPORT

PDF HEART DISEASE STATISTICS 2017 DOWNLOAD

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

ASSESSMENT OF CHRONIC DISEASE PATIENT S ADHERENCE ON MEDICAL OUTCOMES IN DISTRICT SWAT, PAKISTAN

Do Not Cite. Draft for Work Group Review.

Egyptian Hypertension Guidelines

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

Established Risk Factors for Coronary Heart Disease (CHD)

Blood Pressure Lowering Efficacy of Perindopril/ Indapamide Fixed Dose Combination in Uncontrolled Hypertension

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

The Hypertension Clinic is a part of the Internal Medicine

김광일 서울대학교의과대학내과학교실 분당서울대학교병원내과

The University of Mississippi School of Pharmacy

Blood Pressure LIMBO How Low To Go?

Hypertension Guidelines: International; African,?Kenyan

ORIGINAL INVESTIGATION. New Transient Ischemic Attack and Stroke

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF

Blood Pressure Targets: Where are We Now?

None. Disclosure: Relationships with Industry Conflicts of Interests. Learning Objectives: Participants will be able to:

CONTRIBUTING FACTORS FOR STROKE:

ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 patients with diabetes

PRESS RELEASE. New NICE guidance will improve diagnosis and treatment of chronic heart failure

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

National Horizon Scanning Centre. Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation

Health Disparities Research

HYPERTENSION; THE ICE BERG

Achieving Quality and Value in Chronic Care Management

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

Hypertension in the very old. Objectives: Clinical Perspective

Ulster, Ireland. Submitted: 21 June 2009; Revised: 24 January 2010; Published: 13 September 2010 Petrazzuoli F, Soler JK, Buono N, Dobbs F

International Journal of Advancements in Research & Technology, Volume 2, Issue 6, June-2013 ISSN

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

Summary of Research and Writing Activities In Cardiovascular Disease

Prevalence of Hypertension in Semi-Urban area of Nepal

How would you manage Ms. Gold

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Socio-demographic Status & Associated Risk Factors of the Stroke Patient's in a Tertiary Care Hospital of Bangladesh

The presence of cardiovascular disease risk factors, clinical

Original Article FREQUENCY OF HYPERLIPIDEMIA IN PATIENTS OF HYPERTENSION IN CHANDKA MEDICAL COLLEGE HOSPITAL LARKANA CHANNEL JULY - SEPTEMBER 2013

Management of Hypertension for Stroke Prevention in New Zealand: Can We Do Better? Walter van der Merwe Nephrologist Waitemata DHB

UK stroke incidence, mortality and cardiovascular risk management 1999e2008: time-trend analysis from the General Practice Research Database

HEALTHCARE REFORM. September 2012

LLL Session - Nutrition support in diabetes and dyslipidemia. Dyslipidemia: targeting the management of cardiovascular risk factors. M.

Cardiovascular Complications of Diabetes

Regulatory Hurdles for Drug Approvals

CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AT KENYATTA NATIONAL HOSPITAL

Consensus Core Set: Cardiovascular Measures Version 1.0

Update on Current Trends in Hypertension Management

Prevention of Heart Failure: What s New with Hypertension

Myths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!

Primary hypertension in adults

The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease

Current role of low molecular weight heparin in the treatment of acute. ischemic stroke.

The Impact of Smoking on Acute Ischemic Stroke

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

ALLHAT. ALLHAT Antihypertensive Trial Results by Baseline Diabetic & Fasting Glucose Status

Coronary heart disease and stroke

Transcription:

Original Article Knowledge and perceptions of physicians about Evidence Based Management of hypertension in acute ischemic stroke patients ABSTRACT Objective Naveeda Khaliq, Nausheen Hussain, Rabia Akhter, Mobeen Iqbal Department of Medicine, Shifa College of Medicine, Islamabad, Pakistan. We explored knowledge and perceptions of physicians regarding management of hypertension in acute ischemic stroke patients and use of various anti-hypertensive medicines as primary and secondary prevention of stroke. Subjects and Methods A survey was designed with 7 statements derived from the recommendations from American Heart Association (AHA)/American Stroke Association stroke council guidelines 2006 and the 7 th report of the Joint National Committee (JNC VII 2003). Eighty surveys were distributed to the physicians at Shifa College and Shifa International Hospital, and Pakistan Institute of Medical Sciences, Islamabad. Results Fifty surveys were returned and the act of responding was taken as consent for participation. Mean duration from graduation (MBBS) was 10.3±9.9 years. When asked about the management of a BP of 170/90 mm Hg in a patient with acute stroke during first 3 and 24 hours, 58.6% and 60% recommended that patient be treated for this blood pressure on these intervals. When asked about the most effective primary prevention for ischemic stroke in a hypertensive patient, 69.7% thought that lowering blood pressure is 1

the single most important factor and 21.2% thought aspirin as the sole first line primary prevention. 22.5% recommended angiotensin converting enzyme inhibitors and or angiotensin receptor blockers as the primary anti-hypertensive therapy for secondary prevention of a hypertensive ischemic stroke. 50% thought that females do not have higher importance as compared with guidelines. Conclusion There is a considerable gap between evidence based recommendations and actual perceptions of physicians in managing hypertension in stroke patients. This would require an urgent attention to emphasize evidence based practice. (Rawal Med J 2010;35: ). Key Words Hypertension, ischemic stroke, Evidence based practice. INTRODUCTION Stroke remains a major health problem worldwide. 1 It has been shown that stroke is perceived as being worse than death by more than half of people who were at risk of having stroke. 2 From 1968 to 1996 there was 60% decline in stroke mortality in United States and subsequently reached plateau. 3 In past 10 years incidence of stroke is increasing with hypertension being a major modifiable risk factor. 4 Epidemiological data on stroke burden pattern in Pakistan is limited. All the risk factors for stroke like hypertension, diabetes, coronary artery disease, dyslipidemia, and smoking are highly prevalent in Pakistan. 5 A National health survey revealed that more than 30% population above 45 years is suffering from hypertension, 12% population above 15 years is suffering from dyslipidemia and there are 5 million diabetic patients in Pakistan. 6 2

Hypertension is common immediately after acute ischemic stroke mainly due to altered brain auto regulation. In Pakistan, evidence based paradigm is still in its infancy 7 and most of the hospitals do not have stroke protocols or clinical care pathways for acute stroke management. Moreover, the choice of antihypertensive therapy for both primary and secondary prevention of stroke may lack the necessary evidence base. In this study, we explored the perceptions of physicians for immediate management of hypertension and their choice of anti hypertensive drugs in patients with acute ischemic stroke admitted in the hospital. METHODS We conducted this study in two teaching hospitals i.e. Shifa international hospital (SIH) which is a 400 bedded tertiary care center affiliated with Shifa College of Medicine (SCM) and Pakistan Institute of Medical Sciences (PIMS), Islamabad. The study was approved by Shifa International Hospital s ethics committee. We designed a survey containing seven statements derived from evidence-based recommendations of AHA/American Stroke Association & stroke council guidelines published in 2006 and 7 th report of JNC VII for hypertension published in 2003. Survey contained both open ended questions and multiple choice questions. After piloting the survey in 10 post graduate trainees, the statements were modified for clarity. We distributed 80 surveys to the physicians including consultants and postgraduate students working in various specialties of medicine and neurosurgery in both SCM and PIMS. The survey forms were distributed by medical students and physicians were requested to fill out the forms on the spot. Those who did not fill the forms on the spot 3

were excluded from the analysis. This was to ensure that physicians fill out the form with their existing knowledge on the subject. RESULTS Out of 80 surveys 50 forms were filled on the spot. The response rate was 63%. The act of responding to questionnaire was taken as consent for participation in the survey. Respondents included 30 participants from medicine & allied specialties, 6 from neurosurgery and rest from other departments. Fifteen participants had completed one or more post graduate qualifications. Mean duration of graduation (MBBS) of participants was 10.3±9.9 years. Fig 1. Grading of risk factors for stroke in order of significance. response in 5age 90 80 70 60 50 40 30 20 10 0 HTN as 1 Smoking as 3 DM as 2 Dyslipidemia as 4 BMI as 5 4

According to the survey, 58.6 % of participants would treat BP of 180/100 mm of Hg vigorously in an ischemic stroke patient during first three hours of presentation in emergency room. When asked whether they would treat BP of 180/100 mm of Hg in similar patients during next 24 hours, 60% responded in favor of treating hypertension and only 22% wanted to observe while 18% participants did not answer the questions. When asked about controlling BP as a primary prevention of stroke in patients with chronic hypertension, 70% of participants agreed that lowering BP is the single most important factor for primary prevention for stroke in such patients while 21% thought that anti-platelet therapy rather than control of BP as the most important primary prevention strategy for ischemic stroke. When asked about strategies for secondary prevention of ischemic stroke, only 23% recommended using angiotensin converting enzymes inhibitors and/or angiotensin receptor blockers as first line antihypertensive therapy for secondary prevention of ischemic stroke, 41% of participants did not even mention use of any antihypertensive therapy for secondary prevention. Contrary to the evidence, 50% of participants thought that the females do not have high stroke mortality when compared with males. 79% rated hypertension as number one risk factor for stroke (Fig 1). 66.7% of respondents admitted that they did not review any clinical practice guidelines for any disease for at least more than 6 months. DISCUSSION Our survey revealed the misconceptions about stroke management and lack of evidence based practice. Aggressive control of BP in first 24 hours after stroke is still considered 5

important by significant number of physicians. A significant number, however, still lacks the awareness about hypertension as the most important factor for primary and secondary prevention of ischemic stroke. Similarly, most of the physicians still do not have the knowledge about the use of angiotesin converting enzyme inhibitors or angiotensin receptors blockers as the preferred secondary prophylaxis for control of hypertension in patients with a recent ischemic stroke. Another misconception was high mortality in male patients with ischemic stroke. This may reflect gender bias towards healthcare access where males are more frequently taken to tertiary care hospitals due to societal biases. An alarming fact revealed in the survey pertains to the lack of up-to-date knowledge of most of physicians. Lack of time, resources, opportunities for continuous medical education and limited ability to selfassess and self-audit of practices may contribute to this situation. A considerable proportion of patients failed to achieve the guidelines recommended BP targets and this apparent treatment gap was more pronounced amongst female patients. 8 Recently, American stroke association /AHA released new evidence based guidelines for secondary stroke prevention in patients with ischemic stroke and transient ischemic attacks. 9 Evidence based recommendations are set forth for the management of risk factors including hypertension and clinical implementation patterns for primary care physicians. Health care delivery is shifting towards ambulatory services focused around primary care. In a country like Pakistan, it is even more important to create awareness of evidence based management strategies as the resources are limited and use of non- 6

evidence based therapies will only increase morbidity, mortality, cost and health care burden to the already choked delivery system. It is imperative for regulatory bodies to revise curricula at both under and post graduate levels to foster critical thinking, life long learning skills and promote the ability to selfassess. Such an approach will produce doctors who have the ability to reflect on their practice, keep themselves up-to-date and will be skilled in acquiring valid information for patient care independent of pharmaceutical industry sponsored activities. While waiting such a change, emergent steps need to be taken by regulatory bodies like HEC/PMDC and individual institutions to implement evidence based paradigm in both undergraduate and postgraduate medical education. This may include implementing clinical care pathways, regular audit of patient care and developing outcome based quality assurance processes. We also suggest that institutions should have quality monitoring mechanisms and ways where physician promotions are linked with documented continuous professional development activities. Correspondence: Dr. Naveeda Khaliq Senior Registrar Department of Medicine Shifa College of medicine, H-8/4, ISlamabad Kifayat14@hotmail.com Received: October 14, 2009 Accepted: February 16, 2010 REFERENCES 1. American Heart Association. Heart Disease and Stroke Statistics -2004 update. Dallas. Tex: AHA 2003. 7

2. Samsa GP, Matchar DB, Goldstein L, Bonito A, Duncan PW, Lipscomb J, et al. Utilities for major stroke:results from a survey of preferences among persons at increased risk for stroke. Am Heart J 1998;136:703-13. 3. Howard G, Howard VJ, Katholi C, Oli MK, Huston S. Decline in stroke mortality: an analysis of temporal patterns by sex race and geographic region. Stroke 2001;32:1213-20. 4. Brown RD, Whisnant JP, Sicks JD, O Fallow WM, Wiebers DO. Stroke incidence prevalence and survival: Secular trends in Rochester, Minnesota through 1989. Stroke1996;27:373-80. 5. Khealani BA, Wasay M. Burden of stroke in Pakistan. Int J Stroke 2008;3:293-96. 6. Khealani BA, Hameed B, Mapari U. Stroke in Pakistan. JAMA 2008;58:400-403. 7. Zaidi Z, Hashim J, Iqbal M, Quadri KM. Paving the way for Evidence-based medicine in Pakistan. J Pak Med Assoc 2007;57:556-60. 8. Saposnik G, Goodman SG, Leiter LA, Yan RT, Fitchet DH, Bayer NH, et al. Vascular protection; Guidelines-Oriented Approach to Lipid Lowering Registries Investigators; Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals? Stroke 2009;40:1417-24. 9. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnel CD, et al. Primary prevention of stroke: A guideline from the American Heart Association/ American Stroke Association Stroke Council. Stroke 2007;38;207. 8

9